Insulin and type 1 diabetes: immune connections

被引:29
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 101 条
[1]   Modulating the Natural History of Type 1 Diabetes in Children at High Genetic Risk by Mucosal Insulin Immunization [J].
Achenbach, Peter ;
Barker, Jennifer ;
Bonifacio, Ezio .
CURRENT DIABETES REPORTS, 2008, 8 (02) :87-93
[2]   Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B(9-23) epitope [J].
Alleva, DG ;
Maki, RA ;
Putnam, AL ;
Robinson, JM ;
Kipnes, MS ;
Dandona, P ;
Marks, JB ;
Simmons, DL ;
Greenbaum, CJ ;
Jimenez, RG ;
Conlon, PJ ;
Gottlieb, PA .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (01) :59-69
[3]   Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide [J].
Alleva, DG ;
Gaur, A ;
Jin, LP ;
Wegmann, D ;
Gottlieb, PA ;
Pahuja, A ;
Johnson, EB ;
Motheral, T ;
Putnam, A ;
Crowe, PD ;
Ling, N ;
Boehme, SA ;
Conlon, PJ .
DIABETES, 2002, 51 (07) :2126-2134
[4]   A plant-based cholera toxin B subunit - insulin fusion protein protects against the development of autoimmune diabetes [J].
Arakawa, T ;
Yu, J ;
Chong, DKX ;
Hough, J ;
Engen, PC ;
Langridge, WHR .
NATURE BIOTECHNOLOGY, 1998, 16 (10) :934-938
[5]   Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health [J].
Arif, S ;
Tree, TI ;
Astill, TP ;
Tremble, JM ;
Bishop, AJ ;
Dayan, CM ;
Roep, BO ;
Peakman, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :451-463
[6]   ISLET-CELL AUTOANTIGENS IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
MACLAREN, NK .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1608-1616
[7]   INSULITIS AND DIABETES IN NOD MICE REDUCED BY PROPHYLACTIC INSULIN THERAPY [J].
ATKINSON, MA ;
MACLAREN, NK ;
LUCHETTA, R .
DIABETES, 1990, 39 (08) :933-937
[8]   SYNGENEIC TRANSFER OF AUTOIMMUNE DIABETES FROM DIABETIC NOD MICE TO HEALTHY NEONATES - REQUIREMENT FOR BOTH L3T4+ AND LYT-2+ T-CELLS [J].
BENDELAC, A ;
CARNAUD, C ;
BOITARD, C ;
BACH, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :823-832
[9]   Diabetes antibody standardization program: First assay proficiency evaluation [J].
Bingley, PJ ;
Bonifacio, E ;
Mueller, PW .
DIABETES, 2003, 52 (05) :1128-1136
[10]   COMBINED ANALYSIS OF AUTOANTIBODIES IMPROVES PREDICTION OF IDDM IN ISLET-CELL ANTIBODY-POSITIVE RELATIVES [J].
BINGLEY, PJ ;
CHRISTIE, MR ;
BONIFACIO, E ;
BONFANTI, R ;
SHATTOCK, M ;
FONTE, MT ;
BOTTAZZO, GF ;
GALE, EAM .
DIABETES, 1994, 43 (11) :1304-1310